首页> 外文期刊>Chang Gung medical journal >Deceased-Donor Liver Transplantation: 10 Years' Experience at Change Gung Memorial Hospital-Kaohsiung Medical Center
【24h】

Deceased-Donor Liver Transplantation: 10 Years' Experience at Change Gung Memorial Hospital-Kaohsiung Medical Center

机译:死者肝移植:在Change Gung Memorial Hospital-Kaohsiung Medical Center工作了十年

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The purpose of this study was to summarize the outcomes we achieved using deceased-donor liver transplantation (DDLT) in the past 10 years at Chang Gung Memorial Hospital-Kaohsiung Medical Center (CGMH-KMC). Methods: Between March 1993 and March 2003, 53 DDLTs were performed at CGMH-KMC. Patients were divided into 2 stages: stage 1 (n = 22) from March 1993 to February 1998, and stage 2 (n = 31) from March 1998 to March 2003. Indications for transplantation, patient demographics, surgical procedures, and long-term outcomes were reviewed. Results: Indications for transplantation were biliary atresia (16), post-hepatitis B/C viral cirrhosis with or without hepatocellular carcinoma (21), Wilson's disease (8), primary biliary cirrhosis (3), and miscellaneous (5). Two retrans-plants were carried out for secondary biliary cirrhosis using primary live-donor liver transplantation (LDLT). Ten patients received grafts from 6 split-liver transplantations. Over-all Kaplan-Meier 1-, 3-, and 5-year survival rates were 88.46%, 83.86%, and 79.87%, respectively. A significant improvement in patient survival was observed in stage 2. The Kaplan-Meier 1- and 5-year patient survival rates in stage 2 were 96.67% and 92.95%, respectively. Fifteen patients developed vascular complications. Nine patients died in this series for an overall mortality rate of 17%. Conclusions: Deceased-donor liver transplantation is well established as the treatment of choice for acute and chronic liver failure in Taiwan. Satisfactory outcomes have been attained in those transplanted to date.
机译:背景:本研究的目的是总结过去10年在长庚纪念医院-高雄医学中心(CGMH-KMC)进行的死者肝移植(DDLT)获得的结果。方法:从1993年3月至2003年3月,在CGMH-KMC进行了53次DDLT。患者分为2个阶段:1993年3月至1998年2月的1期(n = 22)和1998年3月至2003年3月的2期(n = 31)。移植的适应症,患者的人口统计学,手术方法和长期治疗结果进行了审查。结果:移植适应证为胆道闭锁(16),乙型肝炎/乙型肝炎后病毒性肝硬化伴或不伴肝细胞癌(21),威尔逊病(8),原发性胆汁性肝硬化(3)和其他(5)。使用原发性活体供肝移植(LDLT)对继发性胆汁性肝硬化进行了两次再植。 10例患者接受了6例肝分割移植术。总体而言,Kaplan-Meier的1年,3年和5年生存率分别为88.46%,83.86%和79.87%。在第2阶段观察到患者生存率显着提高。第2阶段的Kaplan-Meier 1年和5年患者生存率分别为96.67%和92.95%。 15名患者出现了血管并发症。该系列中有9名患者死亡,总死亡率为17%。结论:死者肝移植已被确立为台湾急,慢性肝衰竭的首选治疗方法。迄今为止,已经获得了令人满意的结果。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号